{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:04:22Z","timestamp":1786118662514,"version":"build-2736575974"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,1,30]]},"DOI":"10.1097\/qad.0b013e328012b85f","type":"journal-article","created":{"date-parts":[[2007,1,24]],"date-time":"2007-01-24T04:03:11Z","timestamp":1169611391000},"page":"293-305","source":"Crossref","is-referenced-by-count":21,"title":["Early and delayed benefits of HIV-1 suppression: timeline of recovery of innate immunity effector cells"],"prefix":"10.1097","volume":"21","author":[{"given":"Livio","family":"Azzoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihed","family":"Chehimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea S","family":"Foulkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayford","family":"June","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vernon C","family":"Maino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Landay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Rinaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa P","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis J","family":"Montaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210130","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199709113371101","article-title":"A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team","volume":"337","author":"Hammer","year":"1997","journal-title":"N Engl J Med"},{"key":"R2-3-20210130","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/aje\/kwi268","article-title":"Individual variation in CD4 cell count trajectory among human immunodeficiency virus-infected men and women on long-term highly active antiretroviral therapy: an application using a Bayesian random change-point model","volume":"162","author":"Chu","year":"2005","journal-title":"Am J Epidemiol"},{"key":"R3-3-20210130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00002030-200201250-00019","article-title":"The T cell receptor V beta repertoire shows little change during treatment interruption-related viral rebound in chronic HIV infection","volume":"16","author":"Grant","year":"2002","journal-title":"AIDS"},{"key":"R4-3-20210130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0952-7915(00)00245-4","article-title":"Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy","volume":"13","author":"Carcelain","year":"2001","journal-title":"Curr Opin Immunol"},{"key":"R5-3-20210130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jama.280.1.72","article-title":"Recovery of the immune system with antiretroviral therapy: the end of opportunism?","volume":"280","author":"Powderly","year":"1998","journal-title":"JAMA"},{"key":"R6-3-20210130","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1006\/clim.2001.5164","article-title":"CD4+ T-lymphocyte nadir and the effect of highly active antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection","volume":"102","author":"Lange","year":"2002","journal-title":"Clin Immunol"},{"key":"R7-3-20210130","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nm0597-533","article-title":"HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies","volume":"3","author":"Connors","year":"1997","journal-title":"Nat Med"},{"key":"R8-3-20210130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1086\/515591","article-title":"Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315","volume":"178","author":"Lederman","year":"1998","journal-title":"J Infect Dis"},{"key":"R9-3-20210130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0165-2478(98)00159-X","article-title":"Restoration of the immune system with anti-retroviral therapy","volume":"66","author":"Autran","year":"1999","journal-title":"Immunol Lett"},{"key":"R10-3-20210130","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.4049\/jimmunol.173.3.2184","article-title":"Central memory CD4+ T cell responses in chronic HIV infection are not restored by antiretroviral therapy","volume":"173","author":"Elrefaei","year":"2004","journal-title":"J Immunol"},{"key":"R11-3-20210130","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1097\/00002030-200309260-00002","article-title":"Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection","volume":"17","author":"Lange","year":"2003","journal-title":"AIDS"},{"key":"R12-3-20210130","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1086\/379900","article-title":"Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion","volume":"188","author":"Lederman","year":"2003","journal-title":"J Infect Dis"},{"key":"R13-3-20210130","doi-asserted-by":"crossref","first-page":"7534","DOI":"10.4049\/jimmunol.162.12.7534","article-title":"IL-13 and IFN-gamma secretion by activated T cells in HIV-1 infection associated with viral suppression and a lack of disease progression","volume":"162","author":"Bailer","year":"1999","journal-title":"J Immunol"},{"key":"R14-3-20210130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"R15-3-20210130","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.4049\/jimmunol.154.7.3506","article-title":"Functional studies of epidermal Langerhans cells and blood monocytes in HIV-infected persons","volume":"154","author":"Blauvelt","year":"1995","journal-title":"J Immunol"},{"key":"R16-3-20210130","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.4049\/jimmunol.168.9.4796","article-title":"Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals","volume":"168","author":"Chehimi","year":"2002","journal-title":"J Immunol"},{"key":"R17-3-20210130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1749-6632.1984.tb37120.x","article-title":"Deficiency of interferon-alpha generating capacity is associated with susceptibility to opportunistic infections in patients with AIDS","volume":"437","author":"Lopez","year":"1984","journal-title":"Ann N Y Acad Sci"},{"key":"R18-3-20210130","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1182\/blood.V98.8.2574","article-title":"Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load","volume":"98","author":"Donaghy","year":"2001","journal-title":"Blood"},{"key":"R19-3-20210130","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/00002030-200109070-00002","article-title":"Interferon-alpha generation and immune reconstitution during antiretroviral therapy for human immunodeficiency virus infection","volume":"15","author":"Siegal","year":"2001","journal-title":"AIDS"},{"key":"R20-3-20210130","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2249.1998.00590.x","article-title":"Increase in dendritic cell numbers, their function and the proportion uninfected during AZT therapy","volume":"112","author":"Gompels","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"R21-3-20210130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev.immunol.17.1.189","article-title":"Natural killer cells in antiviral defense: function and regulation by innate cytokines","volume":"17","author":"Biron","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"R22-3-20210130","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2174\/1566524023361781","article-title":"NK cells and HIV infection: lessons from other viruses","volume":"2","author":"Scott-Algara","year":"2002","journal-title":"Curr Mol Med"},{"key":"R23-3-20210130","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nri1711","article-title":"NK cells in HIV infection: paradigm for protection or targets for ambush","volume":"5","author":"Fauci","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"R24-3-20210130","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1097\/00002030-199909100-00005","article-title":"Peripheral blood mononuclear cell markers in antiretroviral therapy-naive HIV-infected and high risk seronegative adolescents. Adolescent Medicine HIV\/AIDS Research Network","volume":"13","author":"Douglas","year":"1999","journal-title":"AIDS"},{"key":"R25-3-20210130","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.182.3.789","article-title":"Defective natural immunity: an early manifestation of human immunodeficiency virus infection","volume":"182","author":"Ullum","year":"1995","journal-title":"J Exp Med"},{"key":"R26-3-20210130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/cyto.990220103","article-title":"Evidence of a selective depletion of a CD16+ CD56+ CD8+ natural killer cell subset during HIV infection","volume":"22","author":"Lucia","year":"1995","journal-title":"Cytometry"},{"key":"R27-3-20210130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00042560-199511000-00005","article-title":"Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity","volume":"10","author":"Hu","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R28-3-20210130","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.4049\/jimmunol.168.11.5764","article-title":"Sustained impairment of IFN-gamma secretion in suppressed HIV-infected patients despite mature NK cell recovery: evidence for a defective reconstitution of innate immunity","volume":"168","author":"Azzoni","year":"2002","journal-title":"J Immunol"},{"key":"R29-3-20210130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/jlb.46.1.75","article-title":"Natural killer cell function in patients with acquired immunodeficiency syndrome and related diseases","volume":"46","author":"Brenner","year":"1989","journal-title":"J Leukoc Biol"},{"key":"R30-3-20210130","first-page":"184","article-title":"Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection","volume":"75","author":"Ljunggren","year":"1989","journal-title":"Clin Exp Immunol"},{"key":"R31-3-20210130","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1086\/338929","article-title":"Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen","volume":"185","author":"Le Moing","year":"2002","journal-title":"J Infect Dis"},{"key":"R32-3-20210130","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1084\/jem.179.4.1361","article-title":"Impaired interleukin 12 production in human immunodeficiency virus-infected patients","volume":"94","author":"Chehimi","year":"1994","journal-title":"J Exp Med"},{"key":"R33-3-20210130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0008-8749(88)90061-5","article-title":"Accessory cell requirements for the mixed-leukocyte reaction and polyclonal mitogens, as studied with a new technique for enriching blood dendritic cells","volume":"111","author":"Young","year":"1988","journal-title":"Cell Immunol"},{"key":"R35-3-20210130","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/00002030-200305020-00004","article-title":"The potential for CD4 cell increases in HIV-positive individuals who control viraemia with highly active antiretroviral therapy","volume":"17","author":"Smith","year":"2003","journal-title":"AIDS"},{"key":"R36-3-20210130","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00042560-200106010-00012","article-title":"Increase and plateau of CD4 T-cell counts in the 3(1\/2) years after initiation of potent antiretroviral therapy","volume":"27","author":"Tarwater","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R37-3-20210130","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/00002030-200104130-00009","article-title":"Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study","volume":"15","author":"Yamashita","year":"2001","journal-title":"AIDS"},{"key":"R38-3-20210130","first-page":"206","article-title":"Predictors of CD4+ lymphocyte count among HIV-seropositive and HIV-seronegative pregnant women in Dar es Salaam, Tanzania","volume":"77","author":"Kapiga","year":"2000","journal-title":"East Afr Med J"},{"key":"R39-3-20210130","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1086\/374786","article-title":"T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy","volume":"187","author":"Hunt","year":"2003","journal-title":"J Infect Dis"},{"key":"R40-3-20210130","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00126334-199908150-00004","article-title":"Immune function and phenotype before and after highly active antiretroviral therapy","volume":"21","author":"Sondergaard","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 3","key":"R41-3-20210130","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1097\/00002030-200317003-00003","article-title":"Changes in levels of immune activation and reconstitution markers among HIV-1-infected Africans receiving antiretroviral therapy","volume":"17","author":"Koblavi-Deme","year":"2003","journal-title":"AIDS"},{"key":"R43-3-20210130","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1089\/088922201750461285","article-title":"Multiple CD4+ cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highly active antiretroviral therapy","volume":"17","author":"Wu","year":"2001","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R44-3-20210130","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1182\/blood.V98.10.3016","article-title":"Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection","volume":"98","author":"Pacanowski","year":"2001","journal-title":"Blood"},{"key":"R45-3-20210130","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol"},{"key":"R46-3-20210130","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood.V97.10.3146","article-title":"Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset","volume":"97","author":"Cooper","year":"2001","journal-title":"Blood"},{"key":"R47-3-20210130","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.4049\/jimmunol.173.8.5305","article-title":"Increased natural killer cell activity in viremic HIV-1 infection","volume":"173","author":"Alter","year":"2004","journal-title":"J Immunol"},{"key":"R48-3-20210130","doi-asserted-by":"crossref","first-page":"12365","DOI":"10.1128\/JVI.79.19.12365-12374.2005","article-title":"Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections","volume":"79","author":"Meier","year":"2005","journal-title":"J Virol"},{"key":"R49-3-20210130","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1073\/pnas.0409872102","article-title":"Characterization of CD56-\/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals","volume":"102","author":"Mavilio","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R50-3-20210130","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.4049\/jimmunol.161.6.2938","article-title":"HIV-1 Tat inhibits human natural killer cell function by blocking L- type calcium channels","volume":"161","author":"Zocchi","year":"1998","journal-title":"J Immunol"},{"key":"R51-3-20210130","first-page":"488","article-title":"Dendritic cells and IFN-alpha-producing cells are two functionally distinct non-B, non-monocytic HLA-DR+ cell subsets in human peripheral blood","volume":"68","author":"Chehimi","year":"1989","journal-title":"Immunology"},{"key":"R52-3-20210130","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1182\/blood-2005-03-1100","article-title":"Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection","volume":"106","author":"Alter","year":"2005","journal-title":"Blood"},{"key":"R53-3-20210130","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1086\/382090","article-title":"Expression of chemokine and inhibitory receptors on natural killer cells: effect of immune activation and HIV viremia","volume":"189","author":"Kottilil","year":"2004","journal-title":"J Infect Dis"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAD.0b013e328012b85f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:23:33Z","timestamp":1786033413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200701300-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,30]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e328012b85f","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1,30]]}}}